MedPath

Repeated doses of misoprostol for medical treatment of intact miscarriage

Phase 1
Conditions
Intact miscarriage which has not been expelled from the body (missed abortion)
Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
Registration Number
EUCTR2011-001505-26-SE
Lead Sponsor
Karolinska Institutet
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
899991
Inclusion Criteria

Patients with missed abortion with visible fetal structures without progress in time or stable or sinking levels of s-hcg, over 18 years of age and in good general health, opting for medical treatment and willing to participate in the study will be included.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 140
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients with an empty gestational sac, more than a sparse ongoing bleeding or cervical dilation as signs of ongoing miscarriage, mental instability after the diagnosis or any contraindication to medical treatment such as bleeding disorder or contraindication to any medication given during medical treatment will be excluded

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath